Wedbush Maintains Underperform on Praxis Precision Medicine, Raises Price Target to $77

Benzinga · 11/06/2025 13:30
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and raises the price target from $73 to $77.